Skip to content

Study · Animal study (in vivo) · rat · 1998

9 results

Effects of repeated doses and continuous infusions of the growth hormone-releasing peptide hexarelin in conscious male rats.

Conley LK, Gaillard RC, Giustina A, Brogan RS, Wehrenberg WB

The Journal of endocrinology1 Sept 1998Cited by 12 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study9

9 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In conscious male rats, the GH response (peak and AUC) to the second hexarelin bolus was significantly lower than to the first.

    In plain wordsIn rats, the growth hormone response to a second hexarelin dose two hours later was smaller than to the first dose.

    Peptide
    Hexarelin
    Outcome
    DecreaseGH peak and AUC, second versus first hexarelin injection
    Study

    ratn: not reported in source

    Conscious male Sprague-Dawley rats
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    25 micrograms/kg · intravenous · three boluses at 2 h intervalsAs given in this study (rat).

    Measurements

    Peak GH, first injection
    301 ng/ml
    25 micrograms/kg i.v.
    Peak GH, second injection
    149 ng/ml
    25 micrograms/kg i.v.
    GH AUC, first injection
    5585 ng/ml per 30 min
    25 micrograms/kg i.v.
    GH AUC, second injection
    3056 ng/ml per 30 min
    25 micrograms/kg i.v.

    Source sentences

    Summary
    For both the peak and AUC results there was a significant (P < 0.05) difference in the GH response noted between the first (peak 301 +/- 37 ng/ml; AUC 5585 +/- 700 ng/ml per 30 min) and second (peak 149 +/- 47 ng/ml; AUC 3056 +/- 908 ng/ml per 30 min) injections of hexarelin, but not between the fir…
    2 context sentences
    Summary · context
    On the day of experimentation, these animals received three 25 micrograms/kg i.v. boluses of hexarelin at 2 h intervals with blood sampling at 5, 10, 15, 30, 60, 90 and 120 min after each dose.
    Summary · context
    In the current study, we investigated the effects of hexarelin administered as repeated doses at 2 h intervals or as a continuous 6, 30 or 174 h infusion to conscious male rats.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In conscious male rats, the GH response to the third hexarelin bolus did not differ significantly from the first.

    In plain wordsIn rats, the growth hormone response to a third hexarelin dose did not differ significantly from the response to the first dose.

    Peptide
    Hexarelin
    Outcome
    No significant changeGH peak and AUC, third versus first hexarelin injection
    Study

    ratn: not reported in source

    Conscious male Sprague-Dawley rats
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    25 micrograms/kg · intravenous · three boluses at 2 h intervalsAs given in this study (rat).

    Measurements

    Peak GH, first injection
    301 ng/ml
    25 micrograms/kg i.v.
    Peak GH, third injection
    214 ng/ml
    25 micrograms/kg i.v.
    GH AUC, first injection
    5585 ng/ml per 30 min
    25 micrograms/kg i.v.
    GH AUC, third injection
    3862 ng/ml per 30 min
    25 micrograms/kg i.v.

    Source sentences

    Summary
    For both the peak and AUC results there was a significant (P < 0.05) difference in the GH response noted between the first (peak 301 +/- 37 ng/ml; AUC 5585 +/- 700 ng/ml per 30 min) and second (peak 149 +/- 47 ng/ml; AUC 3056 +/- 908 ng/ml per 30 min) injections of hexarelin, but not between the fir…
    2 context sentences
    Summary · context
    On the day of experimentation, these animals received three 25 micrograms/kg i.v. boluses of hexarelin at 2 h intervals with blood sampling at 5, 10, 15, 30, 60, 90 and 120 min after each dose.
    Summary · context
    In the current study, we investigated the effects of hexarelin administered as repeated doses at 2 h intervals or as a continuous 6, 30 or 174 h infusion to conscious male rats.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In conscious male rats, plasma GH peaked within 40 min of starting a continuous hexarelin infusion and then returned to basal levels.

    In plain wordsIn rats, growth hormone rose within 40 minutes of starting a hexarelin infusion, then soon went back to baseline.

    Peptide
    Hexarelin
    Outcome
    MixedPlasma GH time course during continuous infusion
    Study

    ratn: not reported in source

    Conscious male Sprague-Dawley rats
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    100 micrograms/h · 6, 30 or 174 hAs given in this study (rat).

    Source sentences

    Summary
    Plasma GH concentrations peaked within 40 min of the initiation of infusion, but soon returned to basal levels.
    2 context sentences
    Summary · context
    In a second series of experiments, adult male Sprague-Dawley rats received continuous infusions (100 micrograms/h) of hexarelin or saline (1 ml/h) for 6, 30 or 174 h.
    Summary · context
    In the current study, we investigated the effects of hexarelin administered as repeated doses at 2 h intervals or as a continuous 6, 30 or 174 h infusion to conscious male rats.
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In conscious male rats, mean plasma GH did not differ between any hexarelin or saline infusion group.

    In plain wordsIn rats, average growth hormone levels did not differ between hexarelin and saline infusion groups.

    Peptide
    Hexarelin
    Outcome
    No significant changeMean plasma GH concentration during infusion
    Study

    ratn: not reported in source

    Conscious male Sprague-Dawley rats
    Comparator
    Saline infusion
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    100 micrograms/h · 6, 30 or 174 hAs given in this study (rat).

    Source sentences

    Summary
    Mean plasma GH concentrations did not differ between any of the treatment groups
    2 context sentences
    Summary · context
    In a second series of experiments, adult male Sprague-Dawley rats received continuous infusions (100 micrograms/h) of hexarelin or saline (1 ml/h) for 6, 30 or 174 h.
    Summary · context
    In the current study, we investigated the effects of hexarelin administered as repeated doses at 2 h intervals or as a continuous 6, 30 or 174 h infusion to conscious male rats.
  5. 05AnimalAnimal study (in vivo)Efficacy outcome

    In conscious male rats, no analysed parameter of pulsatile GH release differed between infusion groups.

    In plain wordsIn rats, the pattern of growth hormone pulses did not differ between hexarelin and saline infusion groups.

    Peptide
    Hexarelin
    Outcome
    No significant changeParameters of pulsatile GH release during infusion
    Study

    ratn: not reported in source

    Conscious male Sprague-Dawley rats
    Comparator
    Saline infusion
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    100 micrograms/h · 6, 30 or 174 hAs given in this study (rat).

    Source sentences

    Summary
    nor did any of the parameters of pulsatile hormone release analyzed.
    2 context sentences
    Summary · context
    In a second series of experiments, adult male Sprague-Dawley rats received continuous infusions (100 micrograms/h) of hexarelin or saline (1 ml/h) for 6, 30 or 174 h.
    Summary · context
    In the current study, we investigated the effects of hexarelin administered as repeated doses at 2 h intervals or as a continuous 6, 30 or 174 h infusion to conscious male rats.
  6. 06AnimalAnimal study (in vivo)Efficacy outcome

    In conscious male rats, plasma corticosterone did not differ between hexarelin and saline infusion groups.

    In plain wordsIn rats, corticosterone levels did not differ between hexarelin and saline infusion groups.

    Peptide
    Hexarelin
    Outcome
    No significant changePlasma corticosterone
    Study

    ratn: not reported in source

    Conscious male Sprague-Dawley rats
    Comparator
    Saline infusion
    Outcome group
    Stress hormones · Endocrine and hormones
    Studied dose
    100 micrograms/h · 6, 30 or 174 hAs given in this study (rat).

    Source sentences

    Summary
    No significant differences in plasma corticosterone concentrations were noted between any of the treatment groups.
    2 context sentences
    Summary · context
    In a second series of experiments, adult male Sprague-Dawley rats received continuous infusions (100 micrograms/h) of hexarelin or saline (1 ml/h) for 6, 30 or 174 h.
    Summary · context
    In the current study, we investigated the effects of hexarelin administered as repeated doses at 2 h intervals or as a continuous 6, 30 or 174 h infusion to conscious male rats.
  7. 07AnimalAnimal study (in vivo)Efficacy outcome

    In conscious male rats, a 6 h hexarelin infusion did not significantly raise plasma IGF-I over saline controls.

    In plain wordsIn rats, a 6-hour hexarelin infusion did not significantly raise IGF-I compared with saline.

    Peptide
    Hexarelin
    Outcome
    No significant changePlasma IGF-I after 6 h infusion
    Study

    ratn: not reported in source

    Conscious male Sprague-Dawley rats
    Comparator
    Saline infusion
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    100 micrograms/h · 6 hAs given in this study (rat).

    Measurements

    Plasma IGF-I
    941 ng/ml
    6 h hexarelin
    Plasma IGF-I
    935 ng/ml
    saline controls

    Source sentences

    Summary
    while neither the 6 h (941 +/- 70 ng/ml) nor the 30 h (954 +/- 70 ng/ml) hexarelin infusions resulted in a significant increase in the plasma IGF-I concentrations over those noted in the saline controls (935 +/- 65 ng/ml)
    2 context sentences
    Summary · context
    In a second series of experiments, adult male Sprague-Dawley rats received continuous infusions (100 micrograms/h) of hexarelin or saline (1 ml/h) for 6, 30 or 174 h.
    Summary · context
    In the current study, we investigated the effects of hexarelin administered as repeated doses at 2 h intervals or as a continuous 6, 30 or 174 h infusion to conscious male rats.
  8. 08AnimalAnimal study (in vivo)Efficacy outcome

    In conscious male rats, a 30 h hexarelin infusion did not significantly raise plasma IGF-I over saline controls.

    In plain wordsIn rats, a 30-hour hexarelin infusion did not significantly raise IGF-I compared with saline.

    Peptide
    Hexarelin
    Outcome
    No significant changePlasma IGF-I after 30 h infusion
    Study

    ratn: not reported in source

    Conscious male Sprague-Dawley rats
    Comparator
    Saline infusion
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    100 micrograms/h · 30 hAs given in this study (rat).

    Measurements

    Plasma IGF-I
    954 ng/ml
    30 h hexarelin
    Plasma IGF-I
    935 ng/ml
    saline controls

    Source sentences

    Summary
    while neither the 6 h (941 +/- 70 ng/ml) nor the 30 h (954 +/- 70 ng/ml) hexarelin infusions resulted in a significant increase in the plasma IGF-I concentrations over those noted in the saline controls (935 +/- 65 ng/ml)
    2 context sentences
    Summary · context
    In a second series of experiments, adult male Sprague-Dawley rats received continuous infusions (100 micrograms/h) of hexarelin or saline (1 ml/h) for 6, 30 or 174 h.
    Summary · context
    In the current study, we investigated the effects of hexarelin administered as repeated doses at 2 h intervals or as a continuous 6, 30 or 174 h infusion to conscious male rats.
  9. 09AnimalAnimal study (in vivo)Efficacy outcome

    In conscious male rats, a 174 h hexarelin infusion significantly raised plasma IGF-I over saline controls.

    In plain wordsIn rats, a 174-hour hexarelin infusion raised IGF-I compared with saline.

    Peptide
    Hexarelin
    Outcome
    IncreasePlasma IGF-I after 174 h infusion
    Study

    ratn: not reported in source

    Conscious male Sprague-Dawley rats
    Comparator
    Saline infusion
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    100 micrograms/h · 174 hAs given in this study (rat).

    Measurements

    Plasma IGF-I
    1289 ng/ml
    174 h hexarelin

    Source sentences

    Summary
    a 174 h hexarelin infusion did elicit a significant increase (1289 +/- 42 ng/ml; P < 0.05).
    2 context sentences
    Summary · context
    In a second series of experiments, adult male Sprague-Dawley rats received continuous infusions (100 micrograms/h) of hexarelin or saline (1 ml/h) for 6, 30 or 174 h.
    Summary · context
    In the current study, we investigated the effects of hexarelin administered as repeated doses at 2 h intervals or as a continuous 6, 30 or 174 h infusion to conscious male rats.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 2

    13 Oct 2026, 16:31 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.